Bruin Biometrics

Bruin Biometrics is a commercial-stage medical device and digital health company pioneering sub-epidermal moisture (SEM) assessment technology for pressure injury prevention. Its flagship product, the Provizio® SEM Scanner, is an FDA-cleared and CE-marked device that detects tissue edema (localized swelling) before visible skin damage occurs, enabling proactive intervention. The company complements the scanner with PIPPA™, a digital tool that integrates data into clinical workflows and electronic medical records. BBI operates as a platform company aiming to expand its biometric sensing technology into other preventable chronic conditions.

Proprietary biometric sensor technology based on sub-epidermal moisture (SEM) assessment via biocapacitance measurement. The platform includes a handheld medical device (Provizio SEM Scanner) and a complementary cloud-based digital health software (PIPPA) for data integration and clinical decision support.

BBI is a first-mover with a unique FDA-cleared device for objective, sub-epidermal pressure injury risk assessment. Traditional competition consists of low-tech support surfaces, dressings, and visual assessment protocols. Potential future competitors include other companies developing wearable sensors or imaging technologies for early tissue damage detection, but BBI's clinical evidence and Arjo partnership provide a strong competitive moat.